Latest News

A close-up of hands holding a candle, providing soft illumination in darkness.
In Memoriam
Roger Billica, MD
1954 - 2025
November 16, 2026

Today marks one year since we lost Roger Billica MD, our former Chief Medical Officer.

Roger was an extraordinary physician, scientist, and visionary whose distinguished career included serving as NASA’s Chief of Medical Operations at the Johnson Space Center. His achievements reflected a lifelong commitment to advancing medical science and improving human health. As Kunasan continues its clinical research, I often reflect on the conversations we shared and the questions Roger encouraged us to pursue. He was ahead of his time in so many ways, and I deeply regret that he is no longer here to witness the next chapter of the research he helped inspire.

Roger’s contribution to Kunasan will never be forgotten.

Thank you, Roger, for your friendship, your vision, and for believing.

Paul Mawson

Co-founder & CEO, Kunasan Inc.

Delta Wave Pro

slow wave activity (NREM3) aka delta waves is essential for brain restoration and memory consolidation.

June 2025
Clinical Trial Shows Kunasan Technology Increases Deep Sleep in Adults with Insomnia

A recent randomized clinical trial conducted in partnership with Penn State has shown that Kunasan’s FREQUEN-ZZZ® platform neurostimulation technology significantly increases deep sleep in adults with insomnia symptoms. Improvements were tracked through overnight EEG sleep studies using polysomnography.

Results are now published in this abstract:
“1382: Investigational Sleep Pad Device Increases Deep Sleep of Midlife Adults with Insomnia Symptoms”
View it on Oxford Academic.

Poster presentation at SLEEP2025  titled “Investigational sleep pad device increases deep sleep of midlife adults with insomnia symptoms: A randomized clinical trial”  

These findings underscore the role of slow wave sleep (also known as delta wave sleep) in long-term brain health. As noted in this CNN report, loss of deep sleep is increasingly linked to a higher risk of dementia.

March 2025

Announcement

Dr. Dan Gartenberg Joins Kunasan Inc as Chief Scientist

An Experienced Leader in Sleep Research

We are delighted to announce that Dr. Dan Gartenberg has agreed to join Kunasan Inc as Chief Scientist. Dr. Gartenberg has amassed a wealth of experience in sleep research, which will be invaluable to our team.

During his PhD training, Dr. Gartenberg worked for the Naval Research Laboratory Applied Research in AI, where he honed his skills in conducting empirical research and developing artificial intelligence models of human behavior. These combined skills have been essential in the research and development aspects of various projects and in disseminating scientific research findings.

Over the past decade, Dr. Gartenberg has successfully collaborated with leading sleep scientists, including Co-Investigators Orfeu Buxton at Penn State and Dr. Daniel Taylor at the University of Arizona. Together, they have published numerous papers on topics such as entraining slow wave sleep with sounds, sleep detection on wearables, and conducting clinical trials to develop new treatments for insomnia.

Dr. Gartenberg’s extensive experience and expertise in sleep research make him a perfect fit for Kunasan Inc. We are confident that his contributions will significantly advance our mission and help us achieve new milestones in the field of sleep science.

December 2024

Proof of Concept

FREQUEN-ZZZ Investigational Device POC Randomized Clinical Trial results NOW LIVE!

NREM3 slow-wave sleep was improved with Active sleep pad use relative to Sham, across 3 metrics:
➤ A 36% increase in total minutes
➤ A 42% increase in proportion of total sleep
➤ A 72% decrease in the disruptions per hour

Talk to us

Have any questions or would like to get in touch? Email us at admin@kunasan.com or write us a message below and we will get back to you shortly.


Scroll to Top